Company: TELO
Filing Date: 2025-05-21
Form Type: 8-K
Source: 0001641172-25-011938
Chunk: 0

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-05-21
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item
3.02 Unregistered Sales of Equity Securities.

The
information set forth in Item 5.02 below is incorporated herein by reference.

Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

5.02(b). Resignation of Principal Officer

Effective
May 16, 2025, Michelle Yanez and the Company mutually agreed to release Ms. Yanez from her position as Chief Financial Officer, Treasurer
and Secretary of Telomir Pharmaceuticals, Inc. (the “ Company”), effective on that date. Ms. Yanez’s resignation was
a mutual separation from the Company and was not based on any disagreement with the Company.

5.02(c). Appointment of Principal Officer

Effective
May 15, 2025, the Company appointed Alan Weichselbaum as the Chief Financial Officer of the Company.

Alan
Weichselbaum, CPA, MBA, 61, Chief Financial Officer of the Company since May 2025, brings over 30 years of experience in
corporate finance, capital markets, and strategic advisory across multiple industries. He plays a key leadership role in advancing
the financial and strategic objectives of both companies as they pursue growth through drug development, licensing, and potential
M& A opportunities.

Mr.
Weichselbaum has served as the Chief Financial Officer of MIRA Pharmaceuticals, Inc. since May 2025. Additionally, since 2015, Mr. Weichselbaum
has served as a director of FinWise Bancorp (Nasdaq: FINW), providing oversight and strategic direction to the publicly traded
financial institution. In 2011, he founded The Wexus Group, an outsourced CFO advisory firm that partners with small and mid-sized companies
to support growth, capital structuring, and exit strategies across various sectors.

From
1995 to 2010, he held senior roles on Wall Street, where he served as an equity analyst, managed two hedge funds, and was Chief Executive
Officer of a boutique brokerage firm. His capital markets expertise and experience leading institutional transactions have positioned
him as a trusted advisor in both public and private markets.

Earlier
in his career, Mr. Weichselbaum was Manager of Budgeting and Financial Analysis at Philip Morris Capital Corporation. He began his professional
journey at Price Waterhouse in 1985, working in the firm’s small business division before pursuing